Updates are available Correction dated 2024-09-23
Click to view Correction: https://doi.org/10.1007/s00277-024-06020-3
-
Authors
Fu, Weijun
Bang, Soo-Mee
Huang, Honghui
Kim, Kihyun
Li, Wei
An, Gang
Lee, Je-Jung
Cai, Zhen
Jin, Jie
Wang, Yafei
Chim, Chor Sang
Carson, Robin
Liu, Rui
Zhao, Man
Chen, Xi
Cui, Canchan
Hou, Jian
Wang, Jianxiang
-
Funding
Funding for this research was provided by:
Janssen Research & Development, LLC
- License Information
-
More Information
Article History
Received: 26 April 2024
Accepted: 18 August 2024
First Online: 4 September 2024
Change Date: 23 September 2024
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1007/s00277-024-06020-3
Declarations
:
: The study was conducted in accordance with the ethical principles outlined in the Declaration of Helsinki and Good Clinical Practice and abided by all applicable regulatory requirements. The study protocol and amendments were reviewed and approved by independent ethics committees and institutional review boards at each participating site, and all patients provided written informed consent.
: R.C. is an employee of Janssen Research & Development, LLC and owns stock or stock options. R.L. is an employee of Johnson & Johnson (China) Investment Ltd., Beijing Branch and owns stock or stock options. X.C. and C.C. are employees of Xian Janssen Pharmaceutical Ltd. and own stock or stock options. J.W. served as a member of the board of directors or advisory committees at AbbVie. All other authors have nothing to declare.
